|
18F-Fluciclovine Clinical Trials
5 actively recruiting trials across 3 locations
Also known as: (1r, 3r)-1-amino-3[18F] fluorocyclobutane-1-carboxylic acid, 18F-FACBC, Axumin
Miami, Florida3 trials
18F-Fluciclovine PET Amino Acid Evaluation of Brain Metastasis Treated With Stereotactic Radiosurgery
Miami Cancer Institute
Phase 1
Assess Use of 18F-Fluciclovine for Patients With Large Brain Metastases Treated With Staged Stereotactic Radiosurgery
Miami Cancer Institute
Phase 1
Characterization of 18F-Fluciclovine PET Amino Acid Radiotracer in Resected Brain Metastasis
Miami Cancer Institute at Baptist Health South Florida
Phase 2
Boston, Massachusetts1 trial
Pilot Study for Detection of PSMA-Low CRPC-NE Tumors With Fluciclovine PET/CT
Dana Farber Cancer Institute
Phase 1
Philadelphia, Pennsylvania1 trial
Evaluation of 18F-Fluciclovine Positron Emission Tomography - Magnetic Resonance Imaging (PET-MRI) in LGG
The Children s Hospital of Philadelphia
Early 1
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.